Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity

Prostate cancer is a highly heterogeneous disease, understanding the crosstalk between complex genomic and epigenomic alterations will aid in developing targeted therapeutics. We demonstrate that, even though snail family transcriptional repressor 2 (SNAI2) is frequently amplified in prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzu, Ying Z., Liao, YuRou, Nandakumar, Subhiksha, Sjöström, Martin, Jehane, Lina E., Ghale, Romina, Govindarajan, Barani, Gerke, Travis A., Lee, Gwo‐Shu Mary, Luo, Jian‐Hua, Chinni, Sreenivasa R., Mucci, Lorelei A., Feng, Felix Y., Kantoff, Philip W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251866/
https://www.ncbi.nlm.nih.gov/pubmed/34792282
http://dx.doi.org/10.1002/1878-0261.13140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251866/
https://www.ncbi.nlm.nih.gov/pubmed/34792282
http://dx.doi.org/10.1002/1878-0261.13140

Ejemplares similares